about
Selection of potent chymotrypsin and elastase inhibitors from M13 phage library of basic pancreatic trypsin inhibitor (BPTI).CD3(+)CD8(+)CD28(-) T Lymphocytes in Patients with Lupus Nephritis.CD4(+)CD25(+)CD127(-) and CD4(+)CD25(+)Foxp3(+) Regulatory T Cell Subsets in Mediating Autoimmune Reactivity in Systemic Lupus Erythematosus Patients.The complement cascade and renal disease.Increased Granulocyte Heparanase Activity in Neutrophils from Patients with Lupus Nephritis and Idiopathic Membranous Nephropathy.How different cystoscopy methods influence patient sexual satisfaction, anxiety, and depression levels: a randomized prospective trial.Type of Renal Replacement Therapy (Hemodialysis versus Peritoneal Dialysis) Does Not Affect Cytokine Gene Expression or Clinical Parameters of Renal Transplant Candidates.The influence of warm ischemia elimination on kidney injury during transplantation - clinical and molecular studySignificant infections after hand transplantation in a Polish population.Importance of alpha-helix N-capping motif in stabilization of betabetaalpha fold.Pretransplant Immune- and Apoptosis-Related Gene Expression Is Associated with Kidney Allograft FunctionThe influence of CTLA-4 gene polymorphism on long-term kidney allograft function in Caucasian recipients.Pretransplantation cellular alloreactivity is predictive of acute graft rejection and 1-year graft function in kidney transplant recipients.Impact of donor-dependent genetic factors on long-term renal graft function.C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.Variability in donor-specific alloantibody production after transplantation.A significant role for anti-human leukocyte antigen antibodies and antibody-mediated rejection in the biopsy-for-cause population.Duration of brain death and cold ischemia time, but not warm ischemia time, increases expression of genes associated with apoptosis in transplanted kidneys from deceased donors.Advanced age of renal transplant recipients correlates with increased plasma concentrations of interleukin-6, chemokine ligand 2 (CCL2), and matrix metalloproteinase 2, and urine concentrations of CCL2 and tissue inhibitor of metalloproteinase 1.Increased plasma matrix metalloproteinase-2 (MMP-2), tissue inhibitor of proteinase-1 (TIMP-1), TIMP-2, and urine MMP-2 concentrations correlate with proteinuria in renal transplant recipients.Antibodies against monomeric C-reactive protein - a promising biomarker of lupus nephritis?Lowering of Messenger Ribonucleic Acid Toll-Like Receptors 2-4,9 in Peripheral Blood Mononuclear Cells in Kidney Allograft Recipients, Relationships With Immunosuppressive Treatment, and Delayed Graft Function Occurrence.Immune activation- and regulation-related patterns in stable hand transplant recipientsExtracorporeal Photopheresis as an Antirejection Prophylaxis in Kidney Transplant Recipients: Preliminary ResultsKidney Transplant Outcome Is Associated with Regulatory T Cell Population and Gene Expression Early after TransplantationDissecting aneurysm of the thoracic aorta in a patient with nephrotic syndrome and brucellosisNon-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft lossThe impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomesKidney Injury Due to Warm Ischemia During Transplantation Can Be ReducedPathogenic role of antibodies against monomeric C-reactive protein in tubulointerstitial nephritis and uveitis syndromeThe influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomesHumoral immunity in hand transplantation: anti-HLA and non-HLA responsePreoperative Computed Tomography Parameters and Deterioration of Remaining Kidney Function in Living DonorsPretransplant Immune Interplay Between Donor and Recipient Influences Posttransplant Kidney Allograft FunctionFunctional Activity of the Complement System in Deceased Donors in Relation to Kidney Allograft OutcomeB Cell Activating Factor (BAFF) in Long-term Kidney Transplant Recipients Is Not a Prognostic Marker for Allograft Dysfunction or SurvivalEndothelin A Receptors Expressed in Renal Blood Vessels of Renal Transplant Patients Are Connected With Acute Tubular Necrosis or Antibody-Mediated RejectionSerum 25-Hydroxyvitamin D Level Is Not Related to Regulatory T Cells or Kidney Function in Renal Transplant RecipientsHistopathological Relevance of Angiotensin II Type 1 Receptor in Renal Transplant BiopsyIssues of Immunological and Hemodynamic Monitoring Before and During Kidney Transplantation in Sensitized Heart Transplant Recipient
P50
Q31033084-57EB7017-4519-474D-A84F-3BCFF43C6F1EQ37092939-4BE8F019-0B7E-4A1A-8629-9229427DFB99Q37253583-D629D542-08BF-42C4-AC5C-49B198176B99Q37502706-B398246B-B539-4479-90B0-FD018A33467EQ37611235-BD29A3F9-661F-4CF8-BAED-F9CEC5786CDAQ37642194-34E6C350-B9E7-4565-A2B6-5403E67E40B3Q40666715-743E6F50-1BFE-4891-A03B-1D113E275B8FQ41659179-B5052221-BBEF-4059-9B2C-00B7E9B218ECQ41671179-6266BD9D-FAF3-4595-BDDA-D93C1169B11DQ41882619-DF04B2A5-B71D-4DC2-8A26-147D8F56623DQ42534730-A1A7CD9D-2613-49AD-BAD8-5F41CFC61A5DQ43062981-ADAA6D29-DD73-462E-B437-B408A44223F7Q43254726-EE94181A-4039-415B-80F9-4D7605928FE7Q43688455-FDFF22EA-DF12-450D-8E54-F2D4E8071760Q46894290-F185EC7E-73F2-43D8-97F7-1476E5F689A5Q46894292-CF80B5E1-472D-406E-919C-F74C84A8F2DFQ47578423-8D411F8D-A7D0-4CA4-9F5D-C60BC0C34FDFQ48843179-3BA74576-9B09-491A-BF68-76E0D1E1AFD3Q51014731-1E87A21F-7A62-4D19-A3DD-8DBAB49B9777Q51014736-839E9A55-E359-4B23-9953-6B197599F091Q51097375-62D7663D-1733-4723-BB92-9CF535855809Q51591102-77CD729B-4B65-407E-8ED5-52FB1A8E3AAEQ56894364-57FFCAAE-276E-4B9C-82CD-9B0303DE5969Q56963768-5875B596-CFB0-452E-8124-A0409C9FC8EFQ61802512-763D19B5-A6BB-4BB3-BAEA-DBE515B08634Q79821534-8F475D71-D23A-4C7E-9F75-3C874005CEF6Q85930767-4A3E6FD8-49E7-4C1B-B531-D32F16EA98F9Q86635362-B0BDDBE0-7D56-42D6-A0A4-FF38FA07407BQ86822202-B2A9804D-2F5D-4D68-B953-D4AC9A51D64DQ87479833-E17D8623-4E33-42C2-907A-A848CA7259CDQ88040407-1F432884-6C79-4891-A003-A34065E14FC6Q88126398-B6925AB6-A4FB-4F22-AED6-AA6ADE2B35A2Q90595454-DDFFAA0C-DDD5-4587-A11F-8658A48554C5Q90595509-69DB59EA-5985-4401-B2C5-DB7AD12B7D36Q90595537-CA203DBF-9407-47E6-A0F0-1753EDCFBE88Q90595584-8541E84A-1288-4D3F-BD8F-437FC6778F82Q90595597-B80034A9-251F-45B7-9112-70E34458FDB1Q90595641-4891FC13-342F-4585-AE6B-330D4BC7650BQ90595699-560520C6-0A0E-493E-A5AD-0D2D0D18CBA9Q90595789-FBAB13DB-5E95-4663-B996-2BAEBD529AED
P50
description
Polish researcher
@en
polski naukowiec
@pl
taighdeoir Polannach
@ga
wetenschapper
@nl
name
Katarzyna Kościelska-Kasprzak
@ast
Katarzyna Kościelska-Kasprzak
@ca
Katarzyna Kościelska-Kasprzak
@de
Katarzyna Kościelska-Kasprzak
@en
Katarzyna Kościelska-Kasprzak
@es
Katarzyna Kościelska-Kasprzak
@fr
Katarzyna Kościelska-Kasprzak
@ga
Katarzyna Kościelska-Kasprzak
@gl
Katarzyna Kościelska-Kasprzak
@it
Katarzyna Kościelska-Kasprzak
@nl
type
label
Katarzyna Kościelska-Kasprzak
@ast
Katarzyna Kościelska-Kasprzak
@ca
Katarzyna Kościelska-Kasprzak
@de
Katarzyna Kościelska-Kasprzak
@en
Katarzyna Kościelska-Kasprzak
@es
Katarzyna Kościelska-Kasprzak
@fr
Katarzyna Kościelska-Kasprzak
@ga
Katarzyna Kościelska-Kasprzak
@gl
Katarzyna Kościelska-Kasprzak
@it
Katarzyna Kościelska-Kasprzak
@nl
altLabel
Katarzyna Koscielska-Kasprzak
@en
prefLabel
Katarzyna Kościelska-Kasprzak
@ast
Katarzyna Kościelska-Kasprzak
@ca
Katarzyna Kościelska-Kasprzak
@de
Katarzyna Kościelska-Kasprzak
@en
Katarzyna Kościelska-Kasprzak
@es
Katarzyna Kościelska-Kasprzak
@fr
Katarzyna Kościelska-Kasprzak
@ga
Katarzyna Kościelska-Kasprzak
@gl
Katarzyna Kościelska-Kasprzak
@it
Katarzyna Kościelska-Kasprzak
@nl
P214
P1412
P1559
Katarzyna Kościelska-Kasprzak
@pl
P21
P214
P27
P31
P496
0000-0002-3216-438X
P735
P7859
viaf-311801004